Stamford, CT -- (SBWIRE) -- 01/17/2014 -- Jet Life Penny Stocks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: RXi Pharmaceuticals Corp (OTCMKTS:RXII), Provectus Pharmaceuticals, Inc. (OTCMKTS:PVCT), Sigma Labs Inc (OTCMKTS:SGLB), AVT Inc (OTCMKTS:AVTC)
RXi Pharmaceuticals Corp (OTCMKTS:RXII) opened the session at $4.90, trading in a range of $4.40 - $4.90. The stock showed a negative performance of -5.25% in the last trading session from its previous close of $4.95 and closed at $4.69. The stock traded on a volume of 115,631 shares and the average volume of the stock remained 145,431 shares. RXi Pharmaceuticals Corporation (RXi) is a development-stage company. The Company is a biotechnology company focused on discovering, developing and commercializing therapies addressing medical needs using RNA interference (RNAi)-targeted technologies. As of July 12, 2012, RXi was focusing its internal therapeutic development efforts in fibrosis.
Has RXII Found The Bottom and Ready To Move Up? Find Out Here
Provectus Pharmaceuticals, Inc. (OTCMKTS:PVCT) traded 2.59 million shares in the last business day while the average volume of the stock remained 2.06 million shares. The stock showed a negative movement of -5.00% to end at $2.66. The 52 week range of the stock remained $0.55 - $3.00. Provectus Pharmaceuticals, Inc. is a development-stage pharmaceutical company that is primarily engaged in developing ethical pharmaceuticals for oncology and dermatology indications. The Company develops and focuses to license or market and sells its two prescription drug candidates, PV-10 and PH-10.
Has PVCT Found The Bottom And Ready To Gain Momentum? Find Out Here
Sigma Labs Inc (OTCMKTS:SGLB) reported 4.96 million shares were exchanged during the last trade, while the average volume is about 7.23 million shares. The stock dropped -4.92% and finished the day at $0.116. The beta of the stock is recorded at 7.27. Sigma Labs, Inc. has two wholly-owned subsidiaries, B6 Sigma, Inc. and Sumner & Lawrence Limited (dba Sumner Associates). B6 Sigma, Inc. (B6 Sigma) develops precision manufacturing solutions and advanced materials technologies, as well as Reasearch and Development solutions for first-tier integrators and other commercial firms worldwide. Sumner Associates provide consultants to Federal government and commercial clients seeking productive solutions for development technologies.
Why Should Investors Buy SGLB After the Recent Fall? Just Go Here and Find Out
AVT Inc (OTCMKTS:AVTC) shares dropped -4.88 percent from its previous close of $4.10 to close at $3.90. Traded with volume of 65,705 shares in the prior session and the average volume of the stock remained 235,736 shares. AVT, Inc. is a developer, manufacturer and vending operator of technology based product dispensing solutions and equipment for food access and food product dispensing. As of December 31, 2011, the Company had vending systems throughout the Los Angeles, Orange and Riverside, California counties.
Will AVTC Get Buyers Even After The Recent Rally? Find Out Here
Jet Life Penny Stocks is always searching the market every day for massive penny stock runs before they happen so you don't have to. Our Penny Stock Newsletter also offers free Highly-Professional Grade stock charts and video charts from one of the most experienced and well-respected chartists in the penny stock industry.
Jet Life Penny Stocks is not a registered securities advisor. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides information on highlighted stocks via press releases, newsletters and company website, but this should not be construed as a recommendation to buy or sell. Please visit the company website for a more complete list of risks and disclosures.
Read full disclaimer at: http://www.jetlifepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)